Milestone Payment as Part of its Discovery Alliance with Boehringer Ingelheim received

Evotec AG today announced that its research alliance with Boehringer Ingelheim has reached a milestone triggering a payment of EUR 4.0 million to Evotec. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/milestone-payment-as-part-of-its-discovery-alliance-with-boehringer-ingelheim-received-5065

Weiterlesen

Evotec AG and 4-Antibody AG form strategic collaboration to innovate antibody selection

Evotec AG and 4-Antibody AG today announced the signing of a strategic collaboration agreement under which Evotec will offer a fully integrated antibody discovery and development service. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-ag-and-4-antibody-ag-form-strategic-collaboration-to-innovate-antibody-selection-5059

Weiterlesen

Evotec grants exclusive rights on EVT 401 in China to Conba Pharmaceutical

Evotec AG and Conba Pharmaceutical Co., Ltd. announced today the grant of a development and marketing license on EVT 401, a selective, small molecule P2X7 antagonist, for human indications with exception of ophthalmological, chronic obstructive pulmonary disease and endometriosis in China. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-grants-exclusive-rights-on-evt-401-in-china-to-conba-pharmaceutical-5053

Weiterlesen

Evotec and Active Biotech Extend and Expand Medicinal Chemistry Collaboration

Evotec AG today announced that it has extended and expanded its medicinal chemistry collaboration with Active Biotech AB, to further advance an existing programme, which has entered the lead optimisation phase. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-and-active-biotech-extend-and-expand-medicinal-chemistry-collaboration-5051

Weiterlesen

Evotec and IR Pharma Establish Drug Discovery Alliance in the Field of Respiratory

Evotec AG and IR Pharma today announced that they have entered into an exclusive strategic alliance to provide integrated drug discovery solutions to Pharmaceutical and Biotech companies in the field of Respiratory Diseases. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-and-ir-pharma-establish-drug-discovery-alliance-in-the-field-of-respiratory-5043

Weiterlesen